$NOVN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVEN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NOVEN PHARMACEUTICALS INC. Get notifications about new insider transactions in NOVEN PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.89 | 894 | 8,842 | 4,200 | 3.3 K to 4.2 K (+27.04 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.90 | 1,406 | 13,919 | 3,306 | 1.9 K to 3.3 K (+74.00 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.91 | 100 | 991 | 1,900 | 1.8 K to 1.9 K (+5.56 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.92 | 300 | 2,976 | 1,800 | 1.5 K to 1.8 K (+20.00 %) |
May 14 2008 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Buy | P | 9.98 | 1,500 | 14,970 | 1,500 | 0 to 1.5 K |
May 01 2008 | NOVN | NOVEN PHARMACEUTIC ... | Brandt Peter C. | President and CEO | Option Exercise | A | 9.10 | 311,529 | 2,834,914 | 311,529 | |
May 01 2008 | NOVN | NOVEN PHARMACEUTIC ... | Brandt Peter C. | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 250,000 | 0 to 250 K |
Mar 31 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.73 | 118,000 | 1,148,140 | 3,424,690 | 3.3 M to 3.4 M (+3.57 %) |
Mar 28 2008 | NOVN | NOVEN PHARMACEUTIC ... | WEST COAST ASSET MANAGEMENT IN ... | 10% Owner | Sell | P | 10.95 | 10,250 | 112,238 | 3,601,058 | 3.6 M to 3.6 M (-0.28 %) |
Mar 28 2008 | NOVN | NOVEN PHARMACEUTIC ... | WEST COAST ASSET MANAGEMENT IN ... | 10% Owner | Buy | P | 9.65 | 251,700 | 2,429,408 | 3,611,308 | 3.4 M to 3.6 M (+7.49 %) |
Mar 17 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 10.92 | 100,000 | 1,092,000 | 3,306,690 | 3.2 M to 3.3 M (+3.12 %) |
Jan 03 2008 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Executive VP and In ... | Grant | A | 0.00 | 7,342 | 0 | 13,681 | 6.3 K to 13.7 K (+115.82 %) |
Jan 03 2008 | NOVN | NOVEN PHARMACEUTIC ... | STRAUSS ROBERT C | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | ||
Nov 20 2007 | NOVN | NOVEN PHARMACEUTIC ... | PRICE MICHAEL DENNIS | VP and Chief Financ ... | Option Exercise | A | 13.93 | 62,500 | 870,625 | 62,500 | |
Nov 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Option Exercise | A | 14.54 | 29,806 | 433,379 | 29,806 | |
Nov 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 14.54 | 44,709 | 650,069 | 44,709 | |
Nov 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | A | 14.54 | 52,161 | 758,421 | 52,161 | |
Oct 02 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.05 | 310,000 | 4,975,500 | 3,206,690 | 2.9 M to 3.2 M (+10.70 %) |
Sep 17 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.47 | 35,000 | 576,450 | 2,896,690 | 2.9 M to 2.9 M (+1.22 %) |
Sep 14 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.09 | 25,000 | 402,250 | 2,861,690 | 2.8 M to 2.9 M (+0.88 %) |
Sep 14 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 15.68 | 52,500 | 823,200 | 2,836,690 | 2.8 M to 2.8 M (+1.89 %) |
Sep 12 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 15.48 | 77,500 | 1,199,700 | 2,784,190 | 2.7 M to 2.8 M (+2.86 %) |
Aug 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | SATOW PHILLIP M | Director | Option Exercise | A | 16.67 | 44,297 | 738,431 | 44,297 | |
Aug 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | SATOW PHILLIP M | Director | Grant | A | 0.00 | 8,998 | 0 | 8,998 | 0 to 9 K |
Aug 14 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.78 | 15,000 | 251,700 | 2,706,690 | 2.7 M to 2.7 M (+0.56 %) |
Aug 08 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.20 | 80,000 | 1,296,000 | 2,691,690 | 2.6 M to 2.7 M (+3.06 %) |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 6,609 | 99,994 | 0 | |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.90 | 6,609 | 171,173 | 2,512 | 9.1 K to 2.5 K (-72.46 %) |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 6,609 | 99,994 | 9,121 | 2.5 K to 9.1 K (+263.10 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | YETTER WAYNE P | Director | Grant | A | 0.00 | 4,374 | 0 | 11,192 | 6.8 K to 11.2 K (+64.15 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | SAVAGE ROBERT G | Director | Grant | A | 0.00 | 4,374 | 0 | 10,498 | 6.1 K to 10.5 K (+71.42 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 4,374 | 0 | 10,256 | 5.9 K to 10.3 K (+74.36 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | DENKHAUS DONALD A | Director | Grant | A | 0.00 | 4,374 | 0 | 10,498 | 6.1 K to 10.5 K (+71.42 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | CLARKSON JOHN G | Director | Grant | A | 0.00 | 4,374 | 0 | 10,426 | 6.1 K to 10.4 K (+72.27 %) |
May 22 2007 | NOVN | NOVEN PHARMACEUTIC ... | BRAGINSKY SIDNEY | Director | Grant | A | 0.00 | 4,374 | 0 | 17,192 | 12.8 K to 17.2 K (+34.12 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Option Exercise | M | 13.68 | 7,716 | 105,555 | 23,148 | |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Sell | S | 25.00 | 7,716 | 192,900 | 6,700 | 14.4 K to 6.7 K (-53.52 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Buy | M | 13.68 | 7,716 | 105,555 | 14,416 | 6.7 K to 14.4 K (+115.16 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.68 | 7,716 | 105,555 | 23,148 | |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 1,391 | 21,046 | 6,609 | |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.90 | 7,716 | 192,128 | 2,512 | 10.2 K to 2.5 K (-75.44 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.68 | 7,716 | 105,555 | 10,228 | 2.5 K to 10.2 K (+307.17 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.90 | 1,391 | 34,636 | 2,512 | 3.9 K to 2.5 K (-35.64 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 1,391 | 21,046 | 3,903 | 2.5 K to 3.9 K (+55.37 %) |
Mar 23 2007 | NOVN | NOVEN PHARMACEUTIC ... | STRAUSS ROBERT C | President, CEO & Ch ... | Gift | G | 0.00 | 1,178 | 0 | 174,759 | 175.9 K to 174.8 K (-0.67 %) |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 901 | 11,812 | 19,099 | |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 27.80 | 901 | 25,048 | 6,339 | 7.2 K to 6.3 K (-12.44 %) |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 901 | 11,812 | 7,240 | 6.3 K to 7.2 K (+14.21 %) |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 13.11 | 901 | 11,812 | 19,099 | |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 27.80 | 901 | 25,048 | 0 | 901 to 0 (-100.00 %) |
Feb 09 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 13.11 | 901 | 11,812 | 901 | 0 to 901 |
Jan 29 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 20,000 | |
Jan 29 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 26.80 | 10,000 | 268,000 | 0 | 10 K to 0 (-100.00 %) |
Jan 29 2007 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 13.11 | 10,000 | 131,100 | 10,000 | 0 to 10 K |
Jan 04 2007 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Option Exercise | M | 22.60 | 25,000 | 565,000 | 25,000 | |
Jan 04 2007 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Sell | S | 26.00 | 25,000 | 650,000 | 0 | 25 K to 0 (-100.00 %) |
Jan 04 2007 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Buy | M | 22.60 | 25,000 | 565,000 | 25,000 | 0 to 25 K |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 10.45 | 12,000 | 125,400 | 24,000 | |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.32 | 2,500 | 63,293 | 6,339 | 8.8 K to 6.3 K (-28.28 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.39 | 2,500 | 63,484 | 8,839 | 11.3 K to 8.8 K (-22.05 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.40 | 2,500 | 63,500 | 11,339 | 13.8 K to 11.3 K (-18.06 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.45 | 2,000 | 50,894 | 13,839 | 15.8 K to 13.8 K (-12.63 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.45 | 2,500 | 63,625 | 15,839 | 18.3 K to 15.8 K (-13.63 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 10.45 | 12,000 | 125,400 | 18,539 | 6.5 K to 18.5 K (+183.51 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 10.45 | 12,000 | 125,400 | 24,000 | |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.32 | 2,500 | 63,293 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.39 | 2,500 | 63,484 | 2,500 | 5 K to 2.5 K (-50.00 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.40 | 2,500 | 63,500 | 5,000 | 7.5 K to 5 K (-33.33 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.45 | 2,000 | 50,894 | 7,500 | 9.5 K to 7.5 K (-21.05 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.45 | 2,500 | 63,625 | 9,500 | 12 K to 9.5 K (-20.83 %) |
Dec 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 10.45 | 12,000 | 125,400 | 12,000 | 0 to 12 K |
Dec 06 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Option Exercise | M | 13.68 | 7,715 | 105,541 | 23,149 | |
Dec 06 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Sell | S | 25.00 | 7,715 | 192,875 | 0 | 7.7 K to 0 (-100.00 %) |
Dec 06 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Buy | M | 13.68 | 7,715 | 105,541 | 7,715 | 0 to 7.7 K |
Nov 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Option Exercise | M | 10.45 | 3,333 | 34,830 | 6,668 | |
Nov 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Sell | S | 24.00 | 3,333 | 79,992 | 0 | 3.3 K to 0 (-100.00 %) |
Nov 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Buy | M | 10.45 | 3,333 | 34,830 | 3,333 | 0 to 3.3 K |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | STRAUSS ROBERT C | President, CEO & Ch ... | Option Exercise | A | 22.83 | 81,441 | 1,859,298 | 81,441 | |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Option Exercise | M | 13.11 | 40,000 | 524,400 | 10,000 | |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Option Exercise | M | 10.45 | 29,999 | 313,490 | 20,001 | |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Sell | S | 22.88 | 40,000 | 915,020 | 6,700 | 46.7 K to 6.7 K (-85.65 %) |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Buy | M | 13.11 | 40,000 | 524,400 | 46,700 | 6.7 K to 46.7 K (+597.01 %) |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Sell | S | 22.88 | 29,999 | 686,242 | 6,700 | 36.7 K to 6.7 K (-81.74 %) |
Nov 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | MANTELLE JUAN A | VP and Chief Techni ... | Buy | M | 10.45 | 29,999 | 313,490 | 36,699 | 6.7 K to 36.7 K (+447.75 %) |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 30,000 | |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 25.80 | 10,000 | 258,000 | 0 | 10 K to 0 (-100.00 %) |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 13.11 | 10,000 | 131,100 | 10,000 | 0 to 10 K |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 20,000 | |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 25.80 | 10,000 | 258,000 | 6,339 | 16.3 K to 6.3 K (-61.20 %) |
Oct 27 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 10,000 | 131,100 | 16,339 | 6.3 K to 16.3 K (+157.75 %) |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 13.11 | 9,800 | 128,478 | 40,000 | |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.80 | 9,800 | 243,040 | 0 | 9.8 K to 0 (-100.00 %) |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 13.11 | 9,800 | 128,478 | 9,800 | 0 to 9.8 K |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 7,420 | 97,276 | 30,000 | |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.80 | 7,420 | 184,016 | 6,339 | 13.8 K to 6.3 K (-53.93 %) |
Oct 12 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 7,420 | 97,276 | 13,759 | 6.3 K to 13.8 K (+117.05 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 2,580 | 33,824 | 37,420 | |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.80 | 2,580 | 63,984 | 6,339 | 8.9 K to 6.3 K (-28.93 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 2,580 | 33,824 | 8,919 | 6.3 K to 8.9 K (+40.70 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 13.11 | 200 | 2,622 | 49,800 | |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.81 | 200 | 4,962 | 0 | 200 to 0 (-100.00 %) |
Oct 03 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 13.11 | 200 | 2,622 | 200 | 0 to 200 |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Option Exercise | M | 10.45 | 24,000 | 250,800 | 36,000 | |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.57 | 5,000 | 122,850 | 0 | 5 K to 0 (-100.00 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.46 | 2,500 | 61,150 | 5,000 | 7.5 K to 5 K (-33.33 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.40 | 2,500 | 60,999 | 7,500 | 10 K to 7.5 K (-25.00 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.37 | 2,500 | 60,937 | 10,000 | 12.5 K to 10 K (-20.00 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.35 | 2,500 | 60,868 | 12,500 | 15 K to 12.5 K (-16.67 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.33 | 2,500 | 60,827 | 15,000 | 17.5 K to 15 K (-14.29 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.33 | 2,500 | 60,813 | 17,500 | 20 K to 17.5 K (-12.50 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.29 | 2,500 | 60,725 | 20,000 | 22.5 K to 20 K (-11.11 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Sell | S | 24.26 | 1,500 | 36,390 | 22,500 | 24 K to 22.5 K (-6.25 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | BARRETT DIANE | VP & Chief Financia ... | Buy | M | 10.45 | 24,000 | 250,800 | 24,000 | 0 to 24 K |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 10.45 | 24,000 | 250,800 | 36,000 | |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 40,000 | |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.42 | 3,000 | 73,260 | 6,339 | 9.3 K to 6.3 K (-32.12 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.40 | 2,000 | 48,792 | 9,339 | 11.3 K to 9.3 K (-17.64 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.39 | 7,000 | 170,730 | 11,339 | 18.3 K to 11.3 K (-38.17 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.36 | 1,000 | 24,360 | 18,339 | 19.3 K to 18.3 K (-5.17 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.31 | 5,000 | 121,550 | 19,339 | 24.3 K to 19.3 K (-20.54 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.28 | 2,000 | 48,560 | 24,339 | 26.3 K to 24.3 K (-7.59 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.24 | 1,000 | 24,240 | 26,339 | 27.3 K to 26.3 K (-3.66 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.21 | 3,000 | 72,630 | 27,339 | 30.3 K to 27.3 K (-9.89 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 10.45 | 24,000 | 250,800 | 30,339 | 6.3 K to 30.3 K (+378.61 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.18 | 2,500 | 60,452 | 6,339 | 8.8 K to 6.3 K (-28.28 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 24.11 | 2,500 | 60,275 | 8,839 | 11.3 K to 8.8 K (-22.05 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 23.97 | 2,500 | 59,933 | 11,339 | 13.8 K to 11.3 K (-18.06 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Sell | S | 23.84 | 2,500 | 59,600 | 13,839 | 16.3 K to 13.8 K (-15.30 %) |
Sep 13 2006 | NOVN | NOVEN PHARMACEUTIC ... | EISENBERG JEFFREY F | Sr. VP - Strategic ... | Buy | M | 13.11 | 10,000 | 131,100 | 16,339 | 6.3 K to 16.3 K (+157.75 %) |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Option Exercise | M | 11.12 | 10,000 | 111,200 | 20,000 | |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Sell | S | 25.39 | 10,000 | 253,900 | 0 | 10 K to 0 (-100.00 %) |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | ABRAO EDUARDO G | VP & Chief Medical ... | Buy | M | 11.12 | 10,000 | 111,200 | 10,000 | 0 to 10 K |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 10,000 | |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.38 | 10,000 | 253,790 | 2,512 | 12.5 K to 2.5 K (-79.92 %) |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.11 | 10,000 | 131,100 | 12,512 | 2.5 K to 12.5 K (+398.09 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.45 | 20,000 | 209,000 | 30,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 21,668 | 284,067 | 20,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 8,332 | 109,233 | 41,668 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 16,002 | 242,110 | 8,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.01 | 900 | 22,509 | 2,512 | 3.4 K to 2.5 K (-26.38 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.00 | 40,768 | 1,019,200 | 3,412 | 44.2 K to 3.4 K (-92.28 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.45 | 20,000 | 209,000 | 44,180 | 24.2 K to 44.2 K (+82.71 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.11 | 21,668 | 284,067 | 24,180 | 2.5 K to 24.2 K (+862.58 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.02 | 100 | 2,502 | 2,512 | 2.6 K to 2.5 K (-3.83 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.00 | 24,234 | 605,850 | 2,612 | 26.8 K to 2.6 K (-90.27 %) |